Table 2. Time to ART initiation from diagnosis among PLHIV newly initiated on ART, before (April–June 2015) and during “Treat All” * (April–June 2017) in 50 ePMS ART sites ^ in Harare, Zimbabwe.
| Time to ART
initiation (in days) |
Before “Treat All” | During “Treat All” | ||
|---|---|---|---|---|
| N | (%) | N | (%) | |
| Total | 2289 | (100.0) | 1682 | (100.0) |
| Same day | 112 | (4.9) | 325 | (19.3) |
| 2–7 | 69 | (3.0) | 57 | (3.5) |
| 8–14 | 106 | (4.6) | 45 | (2.7) |
| 15–30 | 121 | (5.3) | 59 | (3.5) |
| 31–90 | 273 | (11.9) | 179 | (10.6) |
| 91–180 | 292 | (12.8) | 239 | (14.2) |
| >180 | 369 | (16.1) | 88 | (5.2) |
| Not recorded | 947 | (41.4) | 690 | (41.0) |
PLHIV: people living with human immunodeficiency virus; ART: antiretroviral therapy; ePMS: electronic patient management system.
*”Treat All” means all individuals with confirmed HIV diagnosis are eligible for ART irrespective of WHO clinical stage or CD4 count.
^As on October 2018, the 50 ePMS sites constituted 52% of all people on ART in Harare province.